Journal
Blood Advances
Publication Date
2-10-2026
Volume
10
Issue
3
First Page
593
Last Page
603
Document Type
Open Access Publication
DOI
10.1182/bloodadvances.2025017862
Rights and Permissions
Anderson DR, Gangaraju R, Sedhom WG, Hamulyák EN, Wang TF, O'Dwyer K, Carney BJ, Muthiah C, Liedtke M, Badar T, Shimony S, Robinson R, Sanfilippo K, Derkach A, Dinner S, Biemond BJ, Nemirovsky D, Goldberg LA, Kapadia AD, Levavi H, Bar-Natan M, Van Hyfte G, Bansal K, Carrier M, Fulcher J, Gerrits AM, Litzow MR, Luger S, Guru Murthy GS, Luskin M, Wolach O, Shomali W, Zwicker JI, Stock W, Leader A. Derivation and external validation of a venous thromboembolism risk prediction model in asparaginase-treated ALL. Blood Adv. 2026 Feb 10;10(3):593-603. doi: 10.1182/bloodadvances.2025017862. © 2026 American Society of Hematology. Published by Elsevier Inc. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved.
Recommended Citation
Anderson, Daniela R; Sanfilippo, Kristen; and et al., "Derivation and external validation of a venous thromboembolism risk prediction model in asparaginase-treated ALL." Blood Advances. 10, 3. 593 - 603. (2026).
https://digitalcommons.wustl.edu/oa_4/6501
Department
ICTS (Institute of Clinical and Translational Sciences)
Additional Links
Supplemental material is available for this article at publisher site.
